Global Galacto-oligosaccharide (GOS) Market By Form (Liquid, Powder) By Age Group (Infants, Adults) By Application ( Prebiotic Activity, Immune System Modulation, Metabolic Syndrome, Antipathogenic Activity, Brain Health, Function & Mood, Athlete Performance/Health, Others) By Distribution Channel (Direct, Indirect) By End Users Industry (Food and Beverage (Dietary Supplements, Bakery and Confectionary Products, Dairy Products, Others) Animal Feeds, Pharmaceuticals) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031
Galacto-Oligosaccharides (GOS) are a kind of carbohydrate that consists of a chain of galactose units. They are formed from lactose and have a structure comparable to the carbohydrates present naturally in human breast milk. Their unusual chemical composition allows them to pass unprocessed into the large intestine, where they serve as prebiotics, promoting the development and activity of beneficial bacteria. In terms of revenue the global galacto-oligosaccharide (GOS) market recorded revenue worth US$ 600 Mn in 2022, anticipated to grow at a CGAR of ~7% during 2023 – 2031.
Global Galacto-Oligosaccharide (GOS) Market Growth Drivers
- Increasing Awareness of Gut Health: There is a growing awareness among consumers about the importance of gut health and its impact on overall well-being. GOS, being a prebiotic that supports the growth of beneficial gut bacteria, has gained popularity as a functional ingredient in various food and beverage products targeted at promoting digestive health.
- Growing Probiotic and Prebiotic Market: The global market for probiotics and prebiotics has been witnessing substantial growth, driven by the rising interest in digestive health and the gut microbiome. GOS falls into the prebiotic category, and its market growth is closely linked to the overall growth of the probiotic and prebiotic market.
Global Galacto-Oligosaccharide (GOS) Market Revenue & Forecast, (US$ Million), 2015 – 2031
As adults are becoming more aware of the importance of gut health and its impact on overall well-being. There has been a growing interest in incorporating prebiotics like GOS into their diets. GOS consumption in adults is often associated with supporting gut health, promoting the growth of beneficial gut bacteria, and potentially enhancing immune function. Adults are consuming GOS through a wider range of products, including dietary supplements, yogurt, beverages, and other functional foods that contain added prebiotics. Thus to cater this demand market participants are introducing GOS products. In June 2022, FrieslandCampina Ingredients, a functional ingredients company, has added the "highest purity" prebiotic Biotis GOS-OP High Purity to its Biotis portfolio for adult gut and brain health, as well as the company's baby feeding solutions. Besides in recent study, a moderate dose of galacto-oligosaccharides (GOS) has been found to reduce the stress hormone cortisol release and emotional processing in healthy individuals. Thus the overall trend of health-conscious consumers has led to the rise in demand for galacto-oligosaccharide (GOS), supporting the growth of the global galacto-oligosaccharide (GOS) market.
In the application segment, food and beverage segment had the highest share in the global galacto-oligosaccharide (GOS) market in 2022. The food and beverage industry is highly using Galacto-oligosaccharides (GOS), as consumers become more health-conscious and aware of the importance of gut health, there is a growing demand for products that support a healthy gut microbiome. GOS's prebiotic functionality makes it a valuable ingredient for promoting digestive health in various food and beverage products. Moreover by incorporating GOS into food and beverages, manufacturers are enhancing the nutritional profile of their products. GOS contributes to the fiber content and can be used to develop products with added health benefits, such as improved gut health and satiety.
Europe had the highest share in the global galacto-oligosaccharide (GOS) market in 2022. As Europe has a well-developed and significant market for infant formula. GOS is commonly added to infant formula products in the region due to its prebiotic properties, which mimic the oligosaccharides naturally found in human breast milk. This inclusion of GOS in infant formulas has contributed to its higher consumption in Europe.
Competitive Landscape
The report provides both, qualitative and quantitative research of global galacto-oligosaccharide (GOS) market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global galacto-oligosaccharide (GOS) market are:
- Azelis
- Clasado
- Fonterra Co-Operative Group Limited
- Friesland Campina.
- Ingredion Germany GmbH
- NATVIE Healthcare Ltd.
- NISSAN SUGAR CO., LTD
- Quantum Hi-Tech (Guangdong) Biological Co., Ltd.
- VW-Ingredients
- Yakult Pharmaceutical.
- Other market participants
Global Galacto-oligosaccharide (GOS) Market
By Form
Liquid
Powder
By Age Group
Infants
Adults
By Application
Prebiotic Activity
Immune System Modulation
Metabolic Syndrome
Antipathogenic Activity
Brain Health, Function & Mood
Athlete Performance/Health
Others
By Distribution Channel
Direct
Indirect
By Applications
Food and Beverage
- Dietary Supplements
- Bakery and Confectionary Products
- Dairy Products
- Others
Animal Feeds
Pharmaceuticals
By Region
North America (U.S., Canada, Mexico, Rest of North America)
Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
Latin America (Brazil, Argentina, Rest of Latin America)
Table of Contents
1.
Market Scope
1.1.
Market Segmentation
1.2.
Years Considered
1.2.1.
Historic Years: 2015 - 2021
1.2.2.
Base Year: 2022
1.2.3.
Forecast Years: 2023 – 2031
2.
Key Target Audiences
3.
Research Methodology
3.1.
Primary Research
3.1.1.
Research Questionnaire
3.1.2.
Global Percentage Breakdown
3.1.3.
Primary Interviews: Key Opinion Leaders
(KOLs)
3.2.
Secondary Research
3.2.1.
Paid Databases
3.2.2.
Secondary Sources
3.3.
Market Size Estimates
3.3.1.
Top-Down Approach
3.3.2.
Bottom-Up Approach
3.4.
Data Triangulation Methodology
3.5.
Research Assumptions
4.
Recommendations and Insights
from AMI’s Perspective**
5.
Holistic Overview of
Galacto-Oligosaccharide (GOS) Market
6.
Market Synopsis: Galacto-Oligosaccharide (GOS) Market
7.
Galacto-Oligosaccharide (GOS)
Market Analysis: Qualitative Perspective
7.1.
Introduction
7.1.1.
Product Definition
7.1.2.
Industry Development
7.2.
Market Dynamics
7.2.1.
Drivers
7.2.2.
Restraints
7.2.3.
Opportunities
7.3.
Trends in Galacto-Oligosaccharide (GOS)
Market
7.4.
Market Determinants Radar Chart
7.5.
Macro-Economic and Micro-Economic
Indicators: Galacto-Oligosaccharide (GOS) Market
7.6.
Porter’s Five Force Analysis
8.
Global Galacto-Oligosaccharide
(GOS) Market Analysis and Forecasts, 2023 – 2031
8.1.
Overview
8.1.1.
Global Galacto-Oligosaccharide (GOS)
Market Revenue (US$ Mn)
8.2.
Global Galacto-Oligosaccharide (GOS)
Market Revenue (US$ Mn) and Forecasts, By Form
8.2.1.
Liquid
8.2.1.1.
Definition
8.2.1.2.
Market Estimation and Penetration,
2015 - 2022
8.2.1.3.
Market Forecast, 2023 - 2031
8.2.1.4.
Compound Annual Growth Rate
(CAGR)
8.2.1.5.
Regional Bifurcation
8.2.1.5.1.
North America
8.2.1.5.1.1.
Market Estimation, 2015 - 2022
8.2.1.5.1.2.
Market Forecast, 2023 - 2031
8.2.1.5.2.
Europe
8.2.1.5.2.1.
Market Estimation, 2015 - 2022
8.2.1.5.2.2.
Market Forecast, 2023 - 2031
8.2.1.5.3.
Asia Pacific
8.2.1.5.3.1.
Market Estimation, 2015 - 2022
8.2.1.5.3.2.
Market Forecast, 2023 - 2031
8.2.1.5.4.
Middle East and Africa
8.2.1.5.4.1.
Market Estimation, 2015 - 2022
8.2.1.5.4.2.
Market Forecast, 2023 - 2031
8.2.1.5.5.
Latin America
8.2.1.5.5.1.
Market Estimation, 2015 - 2022
8.2.1.5.5.2.
Market Forecast, 2023 - 2031
8.2.2.
Powder
8.2.2.1.
Definition
8.2.2.2.
Market Estimation and
Penetration, 2015 - 2022
8.2.2.3.
Market Forecast, 2023 - 2031
8.2.2.4.
Compound Annual Growth Rate
(CAGR)
8.2.2.5.
Regional Bifurcation
8.2.2.5.1.
North America
8.2.2.5.1.1.
Market Estimation, 2015 - 2022
8.2.2.5.1.2.
Market Forecast, 2023 - 2031
8.2.2.5.2.
Europe
8.2.2.5.2.1.
Market Estimation, 2015 - 2022
8.2.2.5.2.2.
Market Forecast, 2023 - 2031
8.2.2.5.3.
Asia Pacific
8.2.2.5.3.1.
Market Estimation, 2015 - 2022
8.2.2.5.3.2.
Market Forecast, 2023 - 2031
8.2.2.5.4.
Middle East and Africa
8.2.2.5.4.1.
Market Estimation, 2015 - 2022
8.2.2.5.4.2.
Market Forecast, 2023 - 2031
8.2.2.5.5.
Latin America
8.2.2.5.5.1.
Market Estimation, 2015 - 2022
8.2.2.5.5.2.
Market Forecast, 2023 - 2031
8.3.
Key Segment for Channeling Investments
8.3.1.
By Form
9.
Global Galacto-Oligosaccharide
(GOS) Market Analysis and Forecasts, 2023 – 2031
9.1.
Overview
9.2.
Global Galacto-Oligosaccharide (GOS)
Market Revenue (US$ Mn) and Forecasts, By Age Group
9.2.1.
Infants
9.2.1.1.
Definition
9.2.1.2.
Market Estimation and
Penetration, 2015 - 2022
9.2.1.3.
Market Forecast, 2023 - 2031
9.2.1.4.
Compound Annual Growth Rate
(CAGR)
9.2.1.5.
Regional Bifurcation
9.2.1.5.1.
North America
9.2.1.5.1.1.
Market Estimation, 2015 - 2022
9.2.1.5.1.2.
Market Forecast, 2023 - 2031
9.2.1.5.2.
Europe
9.2.1.5.2.1.
Market Estimation, 2015 - 2022
9.2.1.5.2.2.
Market Forecast, 2023 - 2031
9.2.1.5.3.
Asia Pacific
9.2.1.5.3.1.
Market Estimation, 2015 - 2022
9.2.1.5.3.2.
Market Forecast, 2023 - 2031
9.2.1.5.4.
Middle East and Africa
9.2.1.5.4.1.
Market Estimation, 2015 - 2022
9.2.1.5.4.2.
Market Forecast, 2023 - 2031
9.2.1.5.5.
Latin America
9.2.1.5.5.1.
Market Estimation, 2015 - 2022
9.2.1.5.5.2.
Market Forecast, 2023 - 2031
9.2.2.
Adults
9.2.2.1.
Definition
9.2.2.2.
Market Estimation and
Penetration, 2015 - 2022
9.2.2.3.
Market Forecast, 2023 - 2031
9.2.2.4.
Compound Annual Growth Rate
(CAGR)
9.2.2.5.
Regional Bifurcation
9.2.2.5.1.
North America
9.2.2.5.1.1.
Market Estimation, 2015 - 2022
9.2.2.5.1.2.
Market Forecast, 2023 - 2031
9.2.2.5.2.
Europe
9.2.2.5.2.1.
Market Estimation, 2015 - 2022
9.2.2.5.2.2.
Market Forecast, 2023 - 2031
9.2.2.5.3.
Asia Pacific
9.2.2.5.3.1.
Market Estimation, 2015 - 2022
9.2.2.5.3.2.
Market Forecast, 2023 - 2031
9.2.2.5.4.
Middle East and Africa
9.2.2.5.4.1.
Market Estimation, 2015 - 2022
9.2.2.5.4.2.
Market Forecast, 2023 - 2031
9.2.2.5.5.
Latin America
9.2.2.5.5.1.
Market Estimation, 2015 - 2022
9.2.2.5.5.2.
Market Forecast, 2023 - 2031
9.3.
Key Segment for Channeling Investments
9.3.1.
By Age Group
10. Global Galacto-Oligosaccharide (GOS) Market Analysis and
Forecasts, 2023 – 2031
10.1.
Overview
10.2.
Global Galacto-Oligosaccharide (GOS)
Market Revenue (US$ Mn) and Forecasts, By Application
10.2.1.
Prebiotic Activity
10.2.1.1.
Definition
10.2.1.2.
Market Estimation and
Penetration, 2015 - 2022
10.2.1.3.
Market Forecast, 2023 - 2031
10.2.1.4.
Compound Annual Growth Rate
(CAGR)
10.2.1.5.
Regional Bifurcation
10.2.1.5.1.
North America
10.2.1.5.1.1.
Market Estimation, 2015 - 2022
10.2.1.5.1.2.
Market Forecast, 2023 - 2031
10.2.1.5.2.
Europe
10.2.1.5.2.1.
Market Estimation, 2015 - 2022
10.2.1.5.2.2.
Market Forecast, 2023 - 2031
10.2.1.5.3.
Asia Pacific
10.2.1.5.3.1.
Market Estimation, 2015 - 2022
10.2.1.5.3.2.
Market Forecast, 2023 - 2031
10.2.1.5.4.
Middle East and Africa
10.2.1.5.4.1.
Market Estimation, 2015 - 2022
10.2.1.5.4.2.
Market Forecast, 2023 - 2031
10.2.1.5.5.
Latin America
10.2.1.5.5.1.
Market Estimation, 2015 - 2022
10.2.1.5.5.2.
Market Forecast, 2023 - 2031
10.2.2.
Immune System Modulation
10.2.2.1.
Definition
10.2.2.2.
Market Estimation and
Penetration, 2015 - 2022
10.2.2.3.
Market Forecast, 2023 - 2031
10.2.2.4.
Compound Annual Growth Rate
(CAGR)
10.2.2.5.
Regional Bifurcation
10.2.2.5.1.
North America
10.2.2.5.1.1.
Market Estimation, 2015 - 2022
10.2.2.5.1.2.
Market Forecast, 2023 - 2031
10.2.2.5.2.
Europe
10.2.2.5.2.1.
Market Estimation, 2015 - 2022
10.2.2.5.2.2.
Market Forecast, 2023 - 2031
10.2.2.5.3.
Asia Pacific
10.2.2.5.3.1.
Market Estimation, 2015 - 2022
10.2.2.5.3.2.
Market Forecast, 2023 - 2031
10.2.2.5.4.
Middle East and Africa
10.2.2.5.4.1.
Market Estimation, 2015 - 2022
10.2.2.5.4.2.
Market Forecast, 2023 - 2031
10.2.2.5.5.
Latin America
10.2.2.5.5.1.
Market Estimation, 2015 - 2022
10.2.2.5.5.2.
Market Forecast, 2023 - 2031
10.2.3.
Metabolic Syndrome
10.2.3.1.
Definition
10.2.3.2.
Market Estimation and
Penetration, 2015 - 2022
10.2.3.3.
Market Forecast, 2023 - 2031
10.2.3.4.
Compound Annual Growth Rate
(CAGR)
10.2.3.5.
Regional Bifurcation
10.2.3.5.1.
North America
10.2.3.5.1.1.
Market Estimation, 2015 - 2022
10.2.3.5.1.2.
Market Forecast, 2023 - 2031
10.2.3.5.2.
Europe
10.2.3.5.2.1.
Market Estimation, 2015 - 2022
10.2.3.5.2.2.
Market Forecast, 2023 - 2031
10.2.3.5.3.
Asia Pacific
10.2.3.5.3.1.
Market Estimation, 2015 - 2022
10.2.3.5.3.2.
Market Forecast, 2023 - 2031
10.2.3.5.4.
Middle East and Africa
10.2.3.5.4.1.
Market Estimation, 2015 - 2022
10.2.3.5.4.2.
Market Forecast, 2023 - 2031
10.2.3.5.5.
Latin America
10.2.3.5.5.1.
Market Estimation, 2015 - 2022
10.2.3.5.5.2.
Market Forecast, 2023 - 2031
10.2.4.
Antipathogenic Activity
10.2.4.1.
Definition
10.2.4.2.
Market Estimation and
Penetration, 2015 - 2022
10.2.4.3.
Market Forecast, 2023 - 2031
10.2.4.4.
Compound Annual Growth Rate
(CAGR)
10.2.4.5.
Regional Bifurcation
10.2.4.5.1.
North America
10.2.4.5.1.1.
Market Estimation, 2015 - 2022
10.2.4.5.1.2.
Market Forecast, 2023 - 2031
10.2.4.5.2.
Europe
10.2.4.5.2.1.
Market Estimation, 2015 - 2022
10.2.4.5.2.2.
Market Forecast, 2023 - 2031
10.2.4.5.3.
Asia Pacific
10.2.4.5.3.1.
Market Estimation, 2015 - 2022
10.2.4.5.3.2.
Market Forecast, 2023 - 2031
10.2.4.5.4.
Middle East and Africa
10.2.4.5.4.1.
Market Estimation, 2015 - 2022
10.2.4.5.4.2.
Market Forecast, 2023 - 2031
10.2.4.5.5.
Latin America
10.2.4.5.5.1.
Market Estimation, 2015 - 2022
10.2.4.5.5.2.
Market Forecast, 2023 - 2031
10.2.5.
Brain Health, Function and Mood
10.2.5.1.
Definition
10.2.5.2.
Market Estimation and
Penetration, 2015 - 2022
10.2.5.3.
Market Forecast, 2023 - 2031
10.2.5.4.
Compound Annual Growth Rate
(CAGR)
10.2.5.5.
Regional Bifurcation
10.2.5.5.1.
North America
10.2.5.5.1.1.
Market Estimation, 2015 - 2022
10.2.5.5.1.2.
Market Forecast, 2023 - 2031
10.2.5.5.2.
Europe
10.2.5.5.2.1.
Market Estimation, 2015 - 2022
10.2.5.5.2.2.
Market Forecast, 2023 - 2031
10.2.5.5.3.
Asia Pacific
10.2.5.5.3.1.
Market Estimation, 2015 - 2022
10.2.5.5.3.2.
Market Forecast, 2023 - 2031
10.2.5.5.4.
Middle East and Africa
10.2.5.5.4.1.
Market Estimation, 2015 - 2022
10.2.5.5.4.2.
Market Forecast, 2023 - 2031
10.2.5.5.5.
Latin America
10.2.5.5.5.1.
Market Estimation, 2015 - 2022
10.2.5.5.5.2.
Market Forecast, 2023 - 2031
10.2.6.
Athlete Performance/Health
10.2.6.1.
Definition
10.2.6.2.
Market Estimation and
Penetration, 2015 - 2022
10.2.6.3.
Market Forecast, 2023 - 2031
10.2.6.4.
Compound Annual Growth Rate
(CAGR)
10.2.6.5.
Regional Bifurcation
10.2.6.5.1.
North America
10.2.6.5.1.1.
Market Estimation, 2015 - 2022
10.2.6.5.1.2.
Market Forecast, 2023 - 2031
10.2.6.5.2.
Europe
10.2.6.5.2.1.
Market Estimation, 2015 - 2022
10.2.6.5.2.2.
Market Forecast, 2023 - 2031
10.2.6.5.3.
Asia Pacific
10.2.6.5.3.1.
Market Estimation, 2015 - 2022
10.2.6.5.3.2.
Market Forecast, 2023 - 2031
10.2.6.5.4.
Middle East and Africa
10.2.6.5.4.1.
Market Estimation, 2015 - 2022
10.2.6.5.4.2.
Market Forecast, 2023 - 2031
10.2.6.5.5.
Latin America
10.2.6.5.5.1.
Market Estimation, 2015 - 2022
10.2.6.5.5.2.
Market Forecast, 2023 - 2031
10.2.7.
Others
10.2.7.1.
Definition
10.2.7.2.
Market Estimation and Penetration,
2015 - 2022
10.2.7.3.
Market Forecast, 2023 - 2031
10.2.7.4.
Compound Annual Growth Rate
(CAGR)
10.2.7.5.
Regional Bifurcation
10.2.7.5.1.
North America
10.2.7.5.1.1.
Market Estimation, 2015 - 2022
10.2.7.5.1.2.
Market Forecast, 2023 - 2031
10.2.7.5.2.
Europe
10.2.7.5.2.1.
Market Estimation, 2015 - 2022
10.2.7.5.2.2.
Market Forecast, 2023 - 2031
10.2.7.5.3.
Asia Pacific
10.2.7.5.3.1.
Market Estimation, 2015 - 2022
10.2.7.5.3.2.
Market Forecast, 2023 - 2031
10.2.7.5.4.
Middle East and Africa
10.2.7.5.4.1.
Market Estimation, 2015 - 2022
10.2.7.5.4.2.
Market Forecast, 2023 - 2031
10.2.7.5.5.
Latin America
10.2.7.5.5.1.
Market Estimation, 2015 - 2022
10.2.7.5.5.2.
Market Forecast, 2023 - 2031
10.3.
Key Segment for Channeling Investments
10.3.1.
By Application
11. Global Galacto-Oligosaccharide (GOS) Market Analysis and
Forecasts, 2023 – 2031
11.1.
Overview
11.2.
Global Galacto-Oligosaccharide (GOS)
Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
11.2.1.
Direct
11.2.1.1.
Definition
11.2.1.2.
Market Estimation and
Penetration, 2015 - 2022
11.2.1.3.
Market Forecast, 2023 - 2031
11.2.1.4.
Compound Annual Growth Rate
(CAGR)
11.2.1.5.
Regional Bifurcation
11.2.1.5.1.
North America
11.2.1.5.1.1.
Market Estimation, 2015 - 2022
11.2.1.5.1.2.
Market Forecast, 2023 - 2031
11.2.1.5.2.
Europe
11.2.1.5.2.1.
Market Estimation, 2015 - 2022
11.2.1.5.2.2.
Market Forecast, 2023 - 2031
11.2.1.5.3.
Asia Pacific
11.2.1.5.3.1.
Market Estimation, 2015 - 2022
11.2.1.5.3.2.
Market Forecast, 2023 - 2031
11.2.1.5.4.
Middle East and Africa
11.2.1.5.4.1.
Market Estimation, 2015 - 2022
11.2.1.5.4.2.
Market Forecast, 2023 - 2031
11.2.1.5.5.
Latin America
11.2.1.5.5.1.
Market Estimation, 2015 - 2022
11.2.1.5.5.2.
Market Forecast, 2023 - 2031
11.2.2.
Indirect
11.2.2.1.
Definition
11.2.2.2.
Market Estimation and
Penetration, 2015 - 2022
11.2.2.3.
Market Forecast, 2023 - 2031
11.2.2.4.
Compound Annual Growth Rate
(CAGR)
11.2.2.5.
Regional Bifurcation
11.2.2.5.1.
North America
11.2.2.5.1.1.
Market Estimation, 2015 - 2022
11.2.2.5.1.2.
Market Forecast, 2023 - 2031
11.2.2.5.2.
Europe
11.2.2.5.2.1.
Market Estimation, 2015 - 2022
11.2.2.5.2.2.
Market Forecast, 2023 - 2031
11.2.2.5.3.
Asia Pacific
11.2.2.5.3.1.
Market Estimation, 2015 - 2022
11.2.2.5.3.2.
Market Forecast, 2023 - 2031
11.2.2.5.4.
Middle East and Africa
11.2.2.5.4.1.
Market Estimation, 2015 - 2022
11.2.2.5.4.2.
Market Forecast, 2023 - 2031
11.2.2.5.5.
Latin America
11.2.2.5.5.1.
Market Estimation, 2015 - 2022
11.2.2.5.5.2.
Market Forecast, 2023 - 2031
11.3.
Key Segment for Channeling Investments
11.3.1.
By Distribution Channel
12. Global Galacto-Oligosaccharide (GOS) Market Analysis and
Forecasts, 2023 – 2031
12.1.
Overview
12.2.
Global Galacto-Oligosaccharide (GOS)
Market Revenue (US$ Mn) and Forecasts, By End Users Industry
12.2.1.
Food and Beverage (Definition, Market Estimation and
Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast
(2023 – 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Dietary Supplements,
Bakery and Confectionary Products , Dairy Products , Others )
12.2.1.1.
Dietary Supplements
12.2.1.2.
Bakery and Confectionary Products
12.2.1.3.
Dairy Products
12.2.1.4.
Others
12.2.2.
Animal Feeds
12.2.2.1.
Definition
12.2.2.2.
Market Estimation and
Penetration, 2015 - 2022
12.2.2.3.
Market Forecast, 2023 - 2031
12.2.2.4.
Compound Annual Growth Rate
(CAGR)
12.2.2.5.
Regional Bifurcation
12.2.2.5.1.
North America
12.2.2.5.1.1.
Market Estimation, 2015 - 2022
12.2.2.5.1.2.
Market Forecast, 2023 - 2031
12.2.2.5.2.
Europe
12.2.2.5.2.1.
Market Estimation, 2015 - 2022
12.2.2.5.2.2.
Market Forecast, 2023 - 2031
12.2.2.5.3.
Asia Pacific
12.2.2.5.3.1.
Market Estimation, 2015 - 2022
12.2.2.5.3.2.
Market Forecast, 2023 - 2031
12.2.2.5.4.
Middle East and Africa
12.2.2.5.4.1.
Market Estimation, 2015 - 2022
12.2.2.5.4.2.
Market Forecast, 2023 - 2031
12.2.2.5.5.
Latin America
12.2.2.5.5.1.
Market Estimation, 2015 - 2022
12.2.2.5.5.2.
Market Forecast, 2023 - 2031
12.2.3.
Pharmaceuticals
12.2.3.1.
Definition
12.2.3.2.
Market Estimation and
Penetration, 2015 - 2022
12.2.3.3.
Market Forecast, 2023 - 2031
12.2.3.4.
Compound Annual Growth Rate
(CAGR)
12.2.3.5.
Regional Bifurcation
12.2.3.5.1.
North America
12.2.3.5.1.1.
Market Estimation, 2015 - 2022
12.2.3.5.1.2.
Market Forecast, 2023 - 2031
12.2.3.5.2.
Europe
12.2.3.5.2.1.
Market Estimation, 2015 - 2022
12.2.3.5.2.2.
Market Forecast, 2023 - 2031
12.2.3.5.3.
Asia Pacific
12.2.3.5.3.1.
Market Estimation, 2015 - 2022
12.2.3.5.3.2.
Market Forecast, 2023 - 2031
12.2.3.5.4.
Middle East and Africa
12.2.3.5.4.1.
Market Estimation, 2015 - 2022
12.2.3.5.4.2.
Market Forecast, 2023 - 2031
12.2.3.5.5.
Latin America
12.2.3.5.5.1.
Market Estimation, 2015 - 2022
12.2.3.5.5.2.
Market Forecast, 2023 - 2031
12.3.
Key Segment for Channeling Investments
12.3.1.
By End Users Industry
13. North America Galacto-Oligosaccharide (GOS) Market Analysis
and Forecasts, 2023 – 2031
13.1.
Overview
13.1.1.
North America Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn)
13.2.
North America Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
13.2.1.
Liquid
13.2.2.
Powder
13.3.
North America Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
13.3.1.
Infants
13.3.2.
Adults
13.4.
North America Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
13.4.1.
Prebiotic Activity
13.4.2.
Immune System Modulation
13.4.3.
Metabolic Syndrome
13.4.4.
Antipathogenic Activity
13.4.5.
Brain Health, Function and Mood
13.4.6.
Athlete Performance/Health
13.4.7.
Others
13.5.
North America Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.5.1.
Direct
13.5.2.
Indirect
13.6.
North America Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
13.6.1.
Food and Beverage
13.6.1.1.
Dietary Supplements
13.6.1.2.
Bakery and Confectionary Products
13.6.1.3.
Dairy Products
13.6.1.4.
Others
13.6.2.
Animal Feeds
13.6.3.
Pharmaceuticals
13.7.
North America Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Country
13.7.1.
U.S
13.7.1.1.
U.S Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
13.7.1.1.1.
Liquid
13.7.1.1.2.
Powder
13.7.1.2.
U.S Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
13.7.1.2.1.
Infants
13.7.1.2.2.
Adults
13.7.1.3.
U.S Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
13.7.1.3.1.
Prebiotic Activity
13.7.1.3.2.
Immune System Modulation
13.7.1.3.3.
Metabolic Syndrome
13.7.1.3.4.
Antipathogenic Activity
13.7.1.3.5.
Brain Health, Function and Mood
13.7.1.3.6.
Athlete Performance/Health
13.7.1.3.7.
Others
13.7.1.4.
U.S Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.7.1.4.1.
Direct
13.7.1.4.2.
Indirect
13.7.1.5.
U.S Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
13.7.1.5.1.
Food and Beverage
13.7.1.5.1.1.
Dietary Supplements
13.7.1.5.1.2.
Bakery and Confectionary Products
13.7.1.5.1.3.
Dairy Products
13.7.1.5.1.4.
Others
13.7.1.5.2.
Animal Feeds
13.7.1.5.3.
Pharmaceuticals
13.7.2.
Canada
13.7.2.1.
Canada Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
13.7.2.1.1.
Liquid
13.7.2.1.2.
Powder
13.7.2.2.
Canada Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
13.7.2.2.1.
Infants
13.7.2.2.2.
Adults
13.7.2.3.
Canada Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
13.7.2.3.1.
Prebiotic Activity
13.7.2.3.2.
Immune System Modulation
13.7.2.3.3.
Metabolic Syndrome
13.7.2.3.4.
Antipathogenic Activity
13.7.2.3.5.
Brain Health, Function and Mood
13.7.2.3.6.
Athlete Performance/Health
13.7.2.3.7.
Others
13.7.2.4.
Canada Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.7.2.4.1.
Direct
13.7.2.4.2.
Indirect
13.7.2.5.
Canada Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
13.7.2.5.1.
Food and Beverage
13.7.2.5.1.1.
Dietary Supplements
13.7.2.5.1.2.
Bakery and Confectionary Products
13.7.2.5.1.3.
Dairy Products
13.7.2.5.1.4.
Others
13.7.2.5.2.
Animal Feeds
13.7.2.5.3.
Pharmaceuticals
13.7.3.
Mexico
13.7.3.1.
Mexico Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
13.7.3.1.1.
Liquid
13.7.3.1.2.
Powder
13.7.3.2.
Mexico Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
13.7.3.2.1.
Infants
13.7.3.2.2.
Adults
13.7.3.3.
Mexico Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
13.7.3.3.1.
Prebiotic Activity
13.7.3.3.2.
Immune System Modulation
13.7.3.3.3.
Metabolic Syndrome
13.7.3.3.4.
Antipathogenic Activity
13.7.3.3.5.
Brain Health, Function and Mood
13.7.3.3.6.
Athlete Performance/Health
13.7.3.3.7.
Others
13.7.3.4.
Mexico Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.7.3.4.1.
Direct
13.7.3.4.2.
Indirect
13.7.3.5.
Mexico Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
13.7.3.5.1.
Food and Beverage
13.7.3.5.1.1.
Dietary Supplements
13.7.3.5.1.2.
Bakery and Confectionary Products
13.7.3.5.1.3.
Dairy Products
13.7.3.5.1.4.
Others
13.7.3.5.2.
Animal Feeds
13.7.3.5.3.
Pharmaceuticals
13.7.4.
Rest of North America
13.7.4.1.
Rest of North America
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Form
13.7.4.1.1.
Liquid
13.7.4.1.2.
Powder
13.7.4.2.
Rest of North America
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Age
Group
13.7.4.2.1.
Infants
13.7.4.2.2.
Adults
13.7.4.3.
Rest of North America
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Application
13.7.4.3.1.
Prebiotic Activity
13.7.4.3.2.
Immune System Modulation
13.7.4.3.3.
Metabolic Syndrome
13.7.4.3.4.
Antipathogenic Activity
13.7.4.3.5.
Brain Health, Function and Mood
13.7.4.3.6.
Athlete Performance/Health
13.7.4.3.7.
Others
13.7.4.4.
Rest of North America
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.7.4.4.1.
Direct
13.7.4.4.2.
Indirect
13.7.4.5.
Rest of North America
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
13.7.4.5.1.
Food and Beverage
13.7.4.5.1.1.
Dietary Supplements
13.7.4.5.1.2.
Bakery and Confectionary Products
13.7.4.5.1.3.
Dairy Products
13.7.4.5.1.4.
Others
13.7.4.5.2.
Animal Feeds
13.7.4.5.3.
Pharmaceuticals
13.8.
Key Segment for Channeling Investments
13.8.1.
By Country
13.8.2.
By Form
13.8.3.
By Age Group
13.8.4.
By Application
13.8.5.
By Distribution Channel
13.8.6.
By End Users Industry
14. Europe Galacto-Oligosaccharide (GOS) Market Analysis and
Forecasts, 2023 – 2031
14.1.
Overview
14.1.1.
Europe Galacto-Oligosaccharide (GOS)
Market Revenue (US$ Mn)
14.2.
Europe Galacto-Oligosaccharide (GOS)
Market Revenue (US$ Mn) and Forecasts, By Form
14.2.1.
Liquid
14.2.2.
Powder
14.3.
Europe Galacto-Oligosaccharide (GOS)
Market Revenue (US$ Mn) and Forecasts, By Age Group
14.3.1.
Infants
14.3.2.
Adults
14.4.
Europe Galacto-Oligosaccharide (GOS)
Market Revenue (US$ Mn) and Forecasts, By Application
14.4.1.
Prebiotic Activity
14.4.2.
Immune System Modulation
14.4.3.
Metabolic Syndrome
14.4.4.
Antipathogenic Activity
14.4.5.
Brain Health, Function and Mood
14.4.6.
Athlete Performance/Health
14.4.7.
Others
14.5.
Europe Galacto-Oligosaccharide (GOS)
Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.5.1.
Direct
14.5.2.
Indirect
14.6.
Europe Galacto-Oligosaccharide (GOS)
Market Revenue (US$ Mn) and Forecasts, By End Users Industry
14.6.1.
Food and Beverage
14.6.1.1.
Dietary Supplements
14.6.1.2.
Bakery and Confectionary Products
14.6.1.3.
Dairy Products
14.6.1.4.
Others
14.6.2.
Animal Feeds
14.6.3.
Pharmaceuticals
14.7.
Europe Galacto-Oligosaccharide (GOS)
Market Revenue (US$ Mn) and Forecasts, By Country
14.7.1.
France
14.7.1.1.
France Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
14.7.1.1.1.
Liquid
14.7.1.1.2.
Powder
14.7.1.2.
France Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
14.7.1.2.1.
Infants
14.7.1.2.2.
Adults
14.7.1.3.
France Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
14.7.1.3.1.
Prebiotic Activity
14.7.1.3.2.
Immune System Modulation
14.7.1.3.3.
Metabolic Syndrome
14.7.1.3.4.
Antipathogenic Activity
14.7.1.3.5.
Brain Health, Function and Mood
14.7.1.3.6.
Athlete Performance/Health
14.7.1.3.7.
Others
14.7.1.4.
France Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.7.1.4.1.
Direct
14.7.1.4.2.
Indirect
14.7.1.5.
France Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
14.7.1.5.1.
Food and Beverage
14.7.1.5.1.1.
Dietary Supplements
14.7.1.5.1.2.
Bakery and Confectionary Products
14.7.1.5.1.3.
Dairy Products
14.7.1.5.1.4.
Others
14.7.1.5.2.
Animal Feeds
14.7.1.5.3.
Pharmaceuticals
14.7.2.
The UK
14.7.2.1.
The UK Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
14.7.2.1.1.
Liquid
14.7.2.1.2.
Powder
14.7.2.2.
The UK Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
14.7.2.2.1.
Infants
14.7.2.2.2.
Adults
14.7.2.3.
The UK Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
14.7.2.3.1.
Prebiotic Activity
14.7.2.3.2.
Immune System Modulation
14.7.2.3.3.
Metabolic Syndrome
14.7.2.3.4.
Antipathogenic Activity
14.7.2.3.5.
Brain Health, Function and Mood
14.7.2.3.6.
Athlete Performance/Health
14.7.2.3.7.
Others
14.7.2.4.
The UK Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.7.2.4.1.
Direct
14.7.2.4.2.
Indirect
14.7.2.5.
The UK Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
14.7.2.5.1.
Food and Beverage
14.7.2.5.1.1.
Dietary Supplements
14.7.2.5.1.2.
Bakery and Confectionary Products
14.7.2.5.1.3.
Dairy Products
14.7.2.5.1.4.
Others
14.7.2.5.2.
Animal Feeds
14.7.2.5.3.
Pharmaceuticals
14.7.3.
Spain
14.7.3.1.
Spain Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
14.7.3.1.1.
Liquid
14.7.3.1.2.
Powder
14.7.3.2.
Spain Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
14.7.3.2.1.
Infants
14.7.3.2.2.
Adults
14.7.3.3.
Spain Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
14.7.3.3.1.
Prebiotic Activity
14.7.3.3.2.
Immune System Modulation
14.7.3.3.3.
Metabolic Syndrome
14.7.3.3.4.
Antipathogenic Activity
14.7.3.3.5.
Brain Health, Function and Mood
14.7.3.3.6.
Athlete Performance/Health
14.7.3.3.7.
Others
14.7.3.4.
Spain Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.7.3.4.1.
Direct
14.7.3.4.2.
Indirect
14.7.3.5.
Spain Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
14.7.3.5.1.
Food and Beverage
14.7.3.5.1.1.
Dietary Supplements
14.7.3.5.1.2.
Bakery and Confectionary Products
14.7.3.5.1.3.
Dairy Products
14.7.3.5.1.4.
Others
14.7.3.5.2.
Animal Feeds
14.7.3.5.3.
Pharmaceuticals
14.7.4.
Germany
14.7.4.1.
Germany Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
14.7.4.1.1.
Liquid
14.7.4.1.2.
Powder
14.7.4.2.
Germany Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
14.7.4.2.1.
Infants
14.7.4.2.2.
Adults
14.7.4.3.
Germany Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
14.7.4.3.1.
Prebiotic Activity
14.7.4.3.2.
Immune System Modulation
14.7.4.3.3.
Metabolic Syndrome
14.7.4.3.4.
Antipathogenic Activity
14.7.4.3.5.
Brain Health, Function and Mood
14.7.4.3.6.
Athlete Performance/Health
14.7.4.3.7.
Others
14.7.4.4.
Germany Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.7.4.4.1.
Direct
14.7.4.4.2.
Indirect
14.7.4.5.
Germany Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
14.7.4.5.1.
Food and Beverage
14.7.4.5.1.1.
Dietary Supplements
14.7.4.5.1.2.
Bakery and Confectionary Products
14.7.4.5.1.3.
Dairy Products
14.7.4.5.1.4.
Others
14.7.4.5.2.
Animal Feeds
14.7.4.5.3.
Pharmaceuticals
14.7.5.
Italy
14.7.5.1.
Italy Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
14.7.5.1.1.
Liquid
14.7.5.1.2.
Powder
14.7.5.2.
Italy Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
14.7.5.2.1.
Infants
14.7.5.2.2.
Adults
14.7.5.3.
Italy Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
14.7.5.3.1.
Prebiotic Activity
14.7.5.3.2.
Immune System Modulation
14.7.5.3.3.
Metabolic Syndrome
14.7.5.3.4.
Antipathogenic Activity
14.7.5.3.5.
Brain Health, Function and Mood
14.7.5.3.6.
Athlete Performance/Health
14.7.5.3.7.
Others
14.7.5.4.
Italy Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.7.5.4.1.
Direct
14.7.5.4.2.
Indirect
14.7.5.5.
Italy Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
14.7.5.5.1.
Food and Beverage
14.7.5.5.1.1.
Dietary Supplements
14.7.5.5.1.2.
Bakery and Confectionary Products
14.7.5.5.1.3.
Dairy Products
14.7.5.5.1.4.
Others
14.7.5.5.2.
Animal Feeds
14.7.5.5.3.
Pharmaceuticals
14.7.6.
Nordic Countries
14.7.6.1.
Nordic Countries
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Form
14.7.6.1.1.
Liquid
14.7.6.1.2.
Powder
14.7.6.2.
Nordic Countries
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Age
Group
14.7.6.2.1.
Infants
14.7.6.2.2.
Adults
14.7.6.3.
Nordic Countries
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.6.3.1.
Prebiotic Activity
14.7.6.3.2.
Immune System Modulation
14.7.6.3.3.
Metabolic Syndrome
14.7.6.3.4.
Antipathogenic Activity
14.7.6.3.5.
Brain Health, Function and Mood
14.7.6.3.6.
Athlete Performance/Health
14.7.6.3.7.
Others
14.7.6.4.
Nordic Countries
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.6.4.1.
Direct
14.7.6.4.2.
Indirect
14.7.6.5.
Nordic Countries
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
14.7.6.5.1.
Food and Beverage
14.7.6.5.1.1.
Dietary Supplements
14.7.6.5.1.2.
Bakery and Confectionary Products
14.7.6.5.1.3.
Dairy Products
14.7.6.5.1.4.
Others
14.7.6.5.2.
Animal Feeds
14.7.6.5.3.
Pharmaceuticals
14.7.6.6.
Nordic Countries
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Country
14.7.6.6.1.
Denmark
14.7.6.6.2.
Finland
14.7.6.6.3.
Iceland
14.7.6.6.4.
Sweden
14.7.6.6.5.
Norway
14.7.7.
Benelux Union
14.7.7.1.
Benelux Union
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Form
14.7.7.1.1.
Liquid
14.7.7.1.2.
Powder
14.7.7.2.
Benelux Union
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Age
Group
14.7.7.2.1.
Infants
14.7.7.2.2.
Adults
14.7.7.3.
Benelux Union
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.7.3.1.
Prebiotic Activity
14.7.7.3.2.
Immune System Modulation
14.7.7.3.3.
Metabolic Syndrome
14.7.7.3.4.
Antipathogenic Activity
14.7.7.3.5.
Brain Health, Function and Mood
14.7.7.3.6.
Athlete Performance/Health
14.7.7.3.7.
Others
14.7.7.4.
Benelux Union
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.7.4.1.
Direct
14.7.7.4.2.
Indirect
14.7.7.5.
Benelux Union
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
14.7.7.5.1.
Food and Beverage
14.7.7.5.1.1.
Dietary Supplements
14.7.7.5.1.2.
Bakery and Confectionary Products
14.7.7.5.1.3.
Dairy Products
14.7.7.5.1.4.
Others
14.7.7.5.2.
Animal Feeds
14.7.7.5.3.
Pharmaceuticals
14.7.7.6.
Benelux Union
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Country
14.7.7.6.1.
Belgium
14.7.7.6.2.
The Netherlands
14.7.7.6.3.
Luxembourg
14.7.8.
Rest of Europe
14.7.8.1.
Rest of Europe
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Form
14.7.8.1.1.
Liquid
14.7.8.1.2.
Powder
14.7.8.2.
Rest of Europe
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Age
Group
14.7.8.2.1.
Infants
14.7.8.2.2.
Adults
14.7.8.3.
Rest of Europe Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
14.7.8.3.1.
Prebiotic Activity
14.7.8.3.2.
Immune System Modulation
14.7.8.3.3.
Metabolic Syndrome
14.7.8.3.4.
Antipathogenic Activity
14.7.8.3.5.
Brain Health, Function and Mood
14.7.8.3.6.
Athlete Performance/Health
14.7.8.3.7.
Others
14.7.8.4.
Rest of Europe
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.8.4.1.
Direct
14.7.8.4.2.
Indirect
14.7.8.5.
Rest of Europe
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
14.7.8.5.1.
Food and Beverage
14.7.8.5.1.1.
Dietary Supplements
14.7.8.5.1.2.
Bakery and Confectionary Products
14.7.8.5.1.3.
Dairy Products
14.7.8.5.1.4.
Others
14.7.8.5.2.
Animal Feeds
14.7.8.5.3.
Pharmaceuticals
14.8.
Key Segment for Channeling Investments
14.8.1.
By Country
14.8.2.
By Form
14.8.3.
By Age Group
14.8.4.
By Application
14.8.5.
By Distribution Channel
14.8.6.
By End Users Industry
15. Asia Pacific Galacto-Oligosaccharide (GOS) Market Analysis
and Forecasts, 2023 – 2031
15.1.
Overview
15.1.1.
Asia Pacific Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn)
15.2.
Asia Pacific Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
15.2.1.
Liquid
15.2.2.
Powder
15.3.
Asia Pacific Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
15.3.1.
Infants
15.3.2.
Adults
15.4.
Asia Pacific Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
15.4.1.
Prebiotic Activity
15.4.2.
Immune System Modulation
15.4.3.
Metabolic Syndrome
15.4.4.
Antipathogenic Activity
15.4.5.
Brain Health, Function and Mood
15.4.6.
Athlete Performance/Health
15.4.7.
Others
15.5.
Asia Pacific Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.5.1.
Direct
15.5.2.
Indirect
15.6.
Asia Pacific Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
15.6.1.
Food and Beverage
15.6.1.1.
Dietary Supplements
15.6.1.2.
Bakery and Confectionary Products
15.6.1.3.
Dairy Products
15.6.1.4.
Others
15.6.2.
Animal Feeds
15.6.3.
Pharmaceuticals
15.7.
Asia Pacific Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Country
15.7.1.
China
15.7.1.1.
China Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
15.7.1.1.1.
Liquid
15.7.1.1.2.
Powder
15.7.1.2.
China Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
15.7.1.2.1.
Infants
15.7.1.2.2.
Adults
15.7.1.3.
China Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
15.7.1.3.1.
Prebiotic Activity
15.7.1.3.2.
Immune System Modulation
15.7.1.3.3.
Metabolic Syndrome
15.7.1.3.4.
Antipathogenic Activity
15.7.1.3.5.
Brain Health, Function and Mood
15.7.1.3.6.
Athlete Performance/Health
15.7.1.3.7.
Others
15.7.1.4.
China Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.7.1.4.1.
Direct
15.7.1.4.2.
Indirect
15.7.1.5.
China Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
15.7.1.5.1.
Food and Beverage
15.7.1.5.1.1.
Dietary Supplements
15.7.1.5.1.2.
Bakery and Confectionary Products
15.7.1.5.1.3.
Dairy Products
15.7.1.5.1.4.
Others
15.7.1.5.2.
Animal Feeds
15.7.1.5.3.
Pharmaceuticals
15.7.2.
Japan
15.7.2.1.
Japan Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
15.7.2.1.1.
Liquid
15.7.2.1.2.
Powder
15.7.2.2.
Japan Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
15.7.2.2.1.
Infants
15.7.2.2.2.
Adults
15.7.2.3.
Japan Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
15.7.2.3.1.
Prebiotic Activity
15.7.2.3.2.
Immune System Modulation
15.7.2.3.3.
Metabolic Syndrome
15.7.2.3.4.
Antipathogenic Activity
15.7.2.3.5.
Brain Health, Function and Mood
15.7.2.3.6.
Athlete Performance/Health
15.7.2.3.7.
Others
15.7.2.4.
Japan Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.7.2.4.1.
Direct
15.7.2.4.2.
Indirect
15.7.2.5.
Japan Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
15.7.2.5.1.
Food and Beverage
15.7.2.5.1.1.
Dietary Supplements
15.7.2.5.1.2.
Bakery and Confectionary Products
15.7.2.5.1.3.
Dairy Products
15.7.2.5.1.4.
Others
15.7.2.5.2.
Animal Feeds
15.7.2.5.3.
Pharmaceuticals
15.7.3.
India
15.7.3.1.
India Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
15.7.3.1.1.
Liquid
15.7.3.1.2.
Powder
15.7.3.2.
India Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
15.7.3.2.1.
Infants
15.7.3.2.2.
Adults
15.7.3.3.
India Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
15.7.3.3.1.
Prebiotic Activity
15.7.3.3.2.
Immune System Modulation
15.7.3.3.3.
Metabolic Syndrome
15.7.3.3.4.
Antipathogenic Activity
15.7.3.3.5.
Brain Health, Function and Mood
15.7.3.3.6.
Athlete Performance/Health
15.7.3.3.7.
Others
15.7.3.4.
India Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.7.3.4.1.
Direct
15.7.3.4.2.
Indirect
15.7.3.5.
India Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
15.7.3.5.1.
Food and Beverage
15.7.3.5.1.1.
Dietary Supplements
15.7.3.5.1.2.
Bakery and Confectionary Products
15.7.3.5.1.3.
Dairy Products
15.7.3.5.1.4.
Others
15.7.3.5.2.
Animal Feeds
15.7.3.5.3.
Pharmaceuticals
15.7.4.
New Zealand
15.7.4.1.
New Zealand
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Form
15.7.4.1.1.
Liquid
15.7.4.1.2.
Powder
15.7.4.2.
New Zealand
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Age
Group
15.7.4.2.1.
Infants
15.7.4.2.2.
Adults
15.7.4.3.
New Zealand
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.4.3.1.
Prebiotic Activity
15.7.4.3.2.
Immune System Modulation
15.7.4.3.3.
Metabolic Syndrome
15.7.4.3.4.
Antipathogenic Activity
15.7.4.3.5.
Brain Health, Function and Mood
15.7.4.3.6.
Athlete Performance/Health
15.7.4.3.7.
Others
15.7.4.4.
New Zealand
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.4.4.1.
Direct
15.7.4.4.2.
Indirect
15.7.4.5.
New Zealand
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
15.7.4.5.1.
Food and Beverage
15.7.4.5.1.1.
Dietary Supplements
15.7.4.5.1.2.
Bakery and Confectionary Products
15.7.4.5.1.3.
Dairy Products
15.7.4.5.1.4.
Others
15.7.4.5.2.
Animal Feeds
15.7.4.5.3.
Pharmaceuticals
15.7.5.
Australia
15.7.5.1.
Australia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Form
15.7.5.1.1.
Liquid
15.7.5.1.2.
Powder
15.7.5.2.
Australia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Age
Group
15.7.5.2.1.
Infants
15.7.5.2.2.
Adults
15.7.5.3.
Australia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.5.3.1.
Prebiotic Activity
15.7.5.3.2.
Immune System Modulation
15.7.5.3.3.
Metabolic Syndrome
15.7.5.3.4.
Antipathogenic Activity
15.7.5.3.5.
Brain Health, Function and Mood
15.7.5.3.6.
Athlete Performance/Health
15.7.5.3.7.
Others
15.7.5.4.
Australia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.5.4.1.
Direct
15.7.5.4.2.
Indirect
15.7.5.5.
Australia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
15.7.5.5.1.
Food and Beverage
15.7.5.5.1.1.
Dietary Supplements
15.7.5.5.1.2.
Bakery and Confectionary Products
15.7.5.5.1.3.
Dairy Products
15.7.5.5.1.4.
Others
15.7.5.5.2.
Animal Feeds
15.7.5.5.3.
Pharmaceuticals
15.7.6.
South Korea
15.7.6.1.
South Korea
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Form
15.7.6.1.1.
Liquid
15.7.6.1.2.
Powder
15.7.6.2.
South Korea
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Age
Group
15.7.6.2.1.
Infants
15.7.6.2.2.
Adults
15.7.6.3.
South Korea
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.6.3.1.
Prebiotic Activity
15.7.6.3.2.
Immune System Modulation
15.7.6.3.3.
Metabolic Syndrome
15.7.6.3.4.
Antipathogenic Activity
15.7.6.3.5.
Brain Health, Function and Mood
15.7.6.3.6.
Athlete Performance/Health
15.7.6.3.7.
Others
15.7.6.4.
South Korea
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.6.4.1.
Direct
15.7.6.4.2.
Indirect
15.7.6.5.
South Korea
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
15.7.6.5.1.
Food and Beverage
15.7.6.5.1.1.
Dietary Supplements
15.7.6.5.1.2.
Bakery and Confectionary Products
15.7.6.5.1.3.
Dairy Products
15.7.6.5.1.4.
Others
15.7.6.5.2.
Animal Feeds
15.7.6.5.3.
Pharmaceuticals
15.7.7.
Southeast Asia
15.7.7.1.
Southeast Asia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Form
15.7.7.1.1.
Liquid
15.7.7.1.2.
Powder
15.7.7.2.
Southeast Asia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Age
Group
15.7.7.2.1.
Infants
15.7.7.2.2.
Adults
15.7.7.3.
Southeast Asia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.7.3.1.
Prebiotic Activity
15.7.7.3.2.
Immune System Modulation
15.7.7.3.3.
Metabolic Syndrome
15.7.7.3.4.
Antipathogenic Activity
15.7.7.3.5.
Brain Health, Function and Mood
15.7.7.3.6.
Athlete Performance/Health
15.7.7.3.7.
Others
15.7.7.4.
Southeast Asia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.7.4.1.
Direct
15.7.7.4.2.
Indirect
15.7.7.5.
Southeast Asia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
15.7.7.5.1.
Food and Beverage
15.7.7.5.1.1.
Dietary Supplements
15.7.7.5.1.2.
Bakery and Confectionary Products
15.7.7.5.1.3.
Dairy Products
15.7.7.5.1.4.
Others
15.7.7.5.2.
Animal Feeds
15.7.7.5.3.
Pharmaceuticals
15.7.7.6.
Southeast Asia Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Country
15.7.7.6.1.
Indonesia
15.7.7.6.2.
Thailand
15.7.7.6.3.
Malaysia
15.7.7.6.4.
Singapore
15.7.7.6.5.
Rest of Southeast Asia
15.7.8.
Rest of Asia Pacific
15.7.8.1.
Rest of Asia Pacific
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Form
15.7.8.1.1.
Liquid
15.7.8.1.2.
Powder
15.7.8.2.
Rest of Asia Pacific
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Age
Group
15.7.8.2.1.
Infants
15.7.8.2.2.
Adults
15.7.8.3.
Rest of Asia Pacific
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.8.3.1.
Prebiotic Activity
15.7.8.3.2.
Immune System Modulation
15.7.8.3.3.
Metabolic Syndrome
15.7.8.3.4.
Antipathogenic Activity
15.7.8.3.5.
Brain Health, Function and Mood
15.7.8.3.6.
Athlete Performance/Health
15.7.8.3.7.
Others
15.7.8.4.
Rest of Asia Pacific
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.8.4.1.
Direct
15.7.8.4.2.
Indirect
15.7.8.5.
Rest of Asia Pacific
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
15.7.8.5.1.
Food and Beverage
15.7.8.5.1.1.
Dietary Supplements
15.7.8.5.1.2.
Bakery and Confectionary Products
15.7.8.5.1.3.
Dairy Products
15.7.8.5.1.4.
Others
15.7.8.5.2.
Animal Feeds
15.7.8.5.3.
Pharmaceuticals
15.8.
Key Segment for Channeling Investments
15.8.1.
By Country
15.8.2.
By Form
15.8.3.
By Age Group
15.8.4.
By Application
15.8.5.
By Distribution Channel
15.8.6.
By End Users Industry
16. Middle East and Africa Galacto-Oligosaccharide (GOS) Market
Analysis and Forecasts, 2023 – 2031
16.1.
Overview
16.1.1.
Middle East and Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn)
16.2.
Middle East and Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Form
16.2.1.
Liquid
16.2.2.
Powder
16.3.
Middle East and Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Age
Group
16.3.1.
Infants
16.3.2.
Adults
16.4.
Middle East and Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Application
16.4.1.
Prebiotic Activity
16.4.2.
Immune System Modulation
16.4.3.
Metabolic Syndrome
16.4.4.
Antipathogenic Activity
16.4.5.
Brain Health, Function and Mood
16.4.6.
Athlete Performance/Health
16.4.7.
Others
16.5.
Middle East and Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.5.1.
Direct
16.5.2.
Indirect
16.6.
Middle East and Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
16.6.1.
Food and Beverage
16.6.1.1.
Dietary Supplements
16.6.1.2.
Bakery and Confectionary Products
16.6.1.3.
Dairy Products
16.6.1.4.
Others
16.6.2.
Animal Feeds
16.6.3.
Pharmaceuticals
16.7.
Middle East and Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Country
16.7.1.
Saudi Arabia
16.7.1.1.
Saudi Arabia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Form
16.7.1.1.1.
Liquid
16.7.1.1.2.
Powder
16.7.1.2.
Saudi Arabia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Age
Group
16.7.1.2.1.
Infants
16.7.1.2.2.
Adults
16.7.1.3.
Saudi Arabia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Application
16.7.1.3.1.
Prebiotic Activity
16.7.1.3.2.
Immune System Modulation
16.7.1.3.3.
Metabolic Syndrome
16.7.1.3.4.
Antipathogenic Activity
16.7.1.3.5.
Brain Health, Function and Mood
16.7.1.3.6.
Athlete Performance/Health
16.7.1.3.7.
Others
16.7.1.4.
Saudi Arabia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.7.1.4.1.
Direct
16.7.1.4.2.
Indirect
16.7.1.5.
Saudi Arabia
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
16.7.1.5.1.
Food and Beverage
16.7.1.5.1.1.
Dietary Supplements
16.7.1.5.1.2.
Bakery and Confectionary Products
16.7.1.5.1.3.
Dairy Products
16.7.1.5.1.4.
Others
16.7.1.5.2.
Animal Feeds
16.7.1.5.3.
Pharmaceuticals
16.7.2.
UAE
16.7.2.1.
UAE Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
16.7.2.1.1.
Liquid
16.7.2.1.2.
Powder
16.7.2.2.
UAE Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
16.7.2.2.1.
Infants
16.7.2.2.2.
Adults
16.7.2.3.
UAE Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
16.7.2.3.1.
Prebiotic Activity
16.7.2.3.2.
Immune System Modulation
16.7.2.3.3.
Metabolic Syndrome
16.7.2.3.4.
Antipathogenic Activity
16.7.2.3.5.
Brain Health, Function and Mood
16.7.2.3.6.
Athlete Performance/Health
16.7.2.3.7.
Others
16.7.2.4.
UAE Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
16.7.2.4.1.
Direct
16.7.2.4.2.
Indirect
16.7.2.5.
UAE Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
16.7.2.5.1.
Food and Beverage
16.7.2.5.1.1.
Dietary Supplements
16.7.2.5.1.2.
Bakery and Confectionary Products
16.7.2.5.1.3.
Dairy Products
16.7.2.5.1.4.
Others
16.7.2.5.2.
Animal Feeds
16.7.2.5.3.
Pharmaceuticals
16.7.3.
Egypt
16.7.3.1.
Egypt Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
16.7.3.1.1.
Liquid
16.7.3.1.2.
Powder
16.7.3.2.
Egypt Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
16.7.3.2.1.
Infants
16.7.3.2.2.
Adults
16.7.3.3.
Egypt Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
16.7.3.3.1.
Prebiotic Activity
16.7.3.3.2.
Immune System Modulation
16.7.3.3.3.
Metabolic Syndrome
16.7.3.3.4.
Antipathogenic Activity
16.7.3.3.5.
Brain Health, Function and Mood
16.7.3.3.6.
Athlete Performance/Health
16.7.3.3.7.
Others
16.7.3.4.
Egypt Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
16.7.3.4.1.
Direct
16.7.3.4.2.
Indirect
16.7.3.5.
Egypt Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
16.7.3.5.1.
Food and Beverage
16.7.3.5.1.1.
Dietary Supplements
16.7.3.5.1.2.
Bakery and Confectionary Products
16.7.3.5.1.3.
Dairy Products
16.7.3.5.1.4.
Others
16.7.3.5.2.
Animal Feeds
16.7.3.5.3.
Pharmaceuticals
16.7.4.
Kuwait
16.7.4.1.
Kuwait Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
16.7.4.1.1.
Liquid
16.7.4.1.2.
Powder
16.7.4.2.
Kuwait Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
16.7.4.2.1.
Infants
16.7.4.2.2.
Adults
16.7.4.3.
Kuwait Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
16.7.4.3.1.
Prebiotic Activity
16.7.4.3.2.
Immune System Modulation
16.7.4.3.3.
Metabolic Syndrome
16.7.4.3.4.
Antipathogenic Activity
16.7.4.3.5.
Brain Health, Function and Mood
16.7.4.3.6.
Athlete Performance/Health
16.7.4.3.7.
Others
16.7.4.4.
Kuwait Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
16.7.4.4.1.
Direct
16.7.4.4.2.
Indirect
16.7.4.5.
Kuwait Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
16.7.4.5.1.
Food and Beverage
16.7.4.5.1.1.
Dietary Supplements
16.7.4.5.1.2.
Bakery and Confectionary Products
16.7.4.5.1.3.
Dairy Products
16.7.4.5.1.4.
Others
16.7.4.5.2.
Animal Feeds
16.7.4.5.3.
Pharmaceuticals
16.7.5.
South Africa
16.7.5.1.
South Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Form
16.7.5.1.1.
Liquid
16.7.5.1.2.
Powder
16.7.5.2.
South Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Age
Group
16.7.5.2.1.
Infants
16.7.5.2.2.
Adults
16.7.5.3.
South Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Application
16.7.5.3.1.
Prebiotic Activity
16.7.5.3.2.
Immune System Modulation
16.7.5.3.3.
Metabolic Syndrome
16.7.5.3.4.
Antipathogenic Activity
16.7.5.3.5.
Brain Health, Function and Mood
16.7.5.3.6.
Athlete Performance/Health
16.7.5.3.7.
Others
16.7.5.4.
South Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.7.5.4.1.
Direct
16.7.5.4.2.
Indirect
16.7.5.5.
South Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
16.7.5.5.1.
Food and Beverage
16.7.5.5.1.1.
Dietary Supplements
16.7.5.5.1.2.
Bakery and Confectionary Products
16.7.5.5.1.3.
Dairy Products
16.7.5.5.1.4.
Others
16.7.5.5.2.
Animal Feeds
16.7.5.5.3.
Pharmaceuticals
16.7.6.
Rest of Middle East & Africa
16.7.6.1.
Rest of Middle East & Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Form
16.7.6.1.1.
Liquid
16.7.6.1.2.
Powder
16.7.6.2.
Rest of Middle East & Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Age
Group
16.7.6.2.1.
Infants
16.7.6.2.2.
Adults
16.7.6.3.
Rest of Middle East & Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Application
16.7.6.3.1.
Prebiotic Activity
16.7.6.3.2.
Immune System Modulation
16.7.6.3.3.
Metabolic Syndrome
16.7.6.3.4.
Antipathogenic Activity
16.7.6.3.5.
Brain Health, Function and Mood
16.7.6.3.6.
Athlete Performance/Health
16.7.6.3.7.
Others
16.7.6.4.
Rest of Middle East & Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.7.6.4.1.
Direct
16.7.6.4.2.
Indirect
16.7.6.5.
Rest of Middle East & Africa
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
16.7.6.5.1.
Food and Beverage
16.7.6.5.1.1.
Dietary Supplements
16.7.6.5.1.2.
Bakery and Confectionary Products
16.7.6.5.1.3.
Dairy Products
16.7.6.5.1.4.
Others
16.7.6.5.2.
Animal Feeds
16.7.6.5.3.
Pharmaceuticals
16.8.
Key Segment for Channeling Investments
16.8.1.
By Country
16.8.2.
By Form
16.8.3.
By Age Group
16.8.4.
By Application
16.8.5.
By Distribution Channel
16.8.6.
By End Users Industry
17. Latin America Galacto-Oligosaccharide (GOS) Market Analysis
and Forecasts, 2023 – 2031
17.1.
Overview
17.1.1.
Latin America Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn)
17.2.
Latin America Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
17.2.1.
Liquid
17.2.2.
Powder
17.3.
Latin America Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
17.3.1.
Infants
17.3.2.
Adults
17.4.
Latin America Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
17.4.1.
Prebiotic Activity
17.4.2.
Immune System Modulation
17.4.3.
Metabolic Syndrome
17.4.4.
Antipathogenic Activity
17.4.5.
Brain Health, Function and Mood
17.4.6.
Athlete Performance/Health
17.4.7.
Others
17.5.
Latin America Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
17.5.1.
Direct
17.5.2.
Indirect
17.6.
Latin America Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
17.6.1.
Food and Beverage
17.6.1.1.
Dietary Supplements
17.6.1.2.
Bakery and Confectionary Products
17.6.1.3.
Dairy Products
17.6.1.4.
Others
17.6.2.
Animal Feeds
17.6.3.
Pharmaceuticals
17.7.
Latin America Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Country
17.7.1.
Brazil
17.7.1.1.
Brazil Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Form
17.7.1.1.1.
Liquid
17.7.1.1.2.
Powder
17.7.1.2.
Brazil Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
17.7.1.2.1.
Infants
17.7.1.2.2.
Adults
17.7.1.3.
Brazil Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Application
17.7.1.3.1.
Prebiotic Activity
17.7.1.3.2.
Immune System Modulation
17.7.1.3.3.
Metabolic Syndrome
17.7.1.3.4.
Antipathogenic Activity
17.7.1.3.5.
Brain Health, Function and Mood
17.7.1.3.6.
Athlete Performance/Health
17.7.1.3.7.
Others
17.7.1.4.
Brazil Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
17.7.1.4.1.
Direct
17.7.1.4.2.
Indirect
17.7.1.5.
Brazil Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By End Users Industry
17.7.1.5.1.
Food and Beverage
17.7.1.5.1.1.
Dietary Supplements
17.7.1.5.1.2.
Bakery and Confectionary Products
17.7.1.5.1.3.
Dairy Products
17.7.1.5.1.4.
Others
17.7.1.5.2.
Animal Feeds
17.7.1.5.3.
Pharmaceuticals
17.7.2.
Argentina
17.7.2.1.
Argentina
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Form
17.7.2.1.1.
Liquid
17.7.2.1.2.
Powder
17.7.2.2.
Argentina Galacto-Oligosaccharide
(GOS) Market Revenue (US$ Mn) and Forecasts, By Age Group
17.7.2.2.1.
Infants
17.7.2.2.2.
Adults
17.7.2.3.
Argentina
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Application
17.7.2.3.1.
Prebiotic Activity
17.7.2.3.2.
Immune System Modulation
17.7.2.3.3.
Metabolic Syndrome
17.7.2.3.4.
Antipathogenic Activity
17.7.2.3.5.
Brain Health, Function and Mood
17.7.2.3.6.
Athlete Performance/Health
17.7.2.3.7.
Others
17.7.2.4.
Argentina
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.7.2.4.1.
Direct
17.7.2.4.2.
Indirect
17.7.2.5.
Argentina
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
17.7.2.5.1.
Food and Beverage
17.7.2.5.1.1.
Dietary Supplements
17.7.2.5.1.2.
Bakery and Confectionary Products
17.7.2.5.1.3.
Dairy Products
17.7.2.5.1.4.
Others
17.7.2.5.2.
Animal Feeds
17.7.2.5.3.
Pharmaceuticals
17.7.3.
Rest of Latin America
17.7.3.1.
Rest of Latin America
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Form
17.7.3.1.1.
Liquid
17.7.3.1.2.
Powder
17.7.3.2.
Rest of Latin America
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By Age
Group
17.7.3.2.1.
Infants
17.7.3.2.2.
Adults
17.7.3.3.
Rest of Latin America
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Application
17.7.3.3.1.
Prebiotic Activity
17.7.3.3.2.
Immune System Modulation
17.7.3.3.3.
Metabolic Syndrome
17.7.3.3.4.
Antipathogenic Activity
17.7.3.3.5.
Brain Health, Function and Mood
17.7.3.3.6.
Athlete Performance/Health
17.7.3.3.7.
Others
17.7.3.4.
Rest of Latin America
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.7.3.4.1.
Direct
17.7.3.4.2.
Indirect
17.7.3.5.
Rest of Latin America
Galacto-Oligosaccharide (GOS) Market Revenue (US$ Mn) and Forecasts, By End
Users Industry
17.7.3.5.1.
Food and Beverage
17.7.3.5.1.1.
Dietary Supplements
17.7.3.5.1.2.
Bakery and Confectionary Products
17.7.3.5.1.3.
Dairy Products
17.7.3.5.1.4.
Others
17.7.3.5.2.
Animal Feeds
17.7.3.5.3.
Pharmaceuticals
17.8.
Key Segment for Channeling Investments
17.8.1.
By Country
17.8.2.
By Form
17.8.3.
By Age Group
17.8.4.
By Application
17.8.5.
By Distribution Channel
17.8.6.
By End Users Industry
18. Competitive Benchmarking
18.1.
Market Share Analysis, 2022
18.2.
Global Presence and Growth Strategies
18.2.1.
Mergers and Acquisitions
18.2.2.
Product Launches
18.2.3.
Investments Trends
18.2.4.
R&D Initiatives
19. Player Profiles
19.1.
Azelis
19.1.1.
Company Details
19.1.2.
Company Overview
19.1.3.
Product Offerings
19.1.4.
Key Developments
19.1.5.
Financial Analysis
19.1.6.
SWOT Analysis
19.1.7.
Business Strategies
19.2.
Clasado
19.2.1.
Company Details
19.2.2.
Company Overview
19.2.3.
Product Offerings
19.2.4.
Key Developments
19.2.5.
Financial Analysis
19.2.6.
SWOT Analysis
19.2.7.
Business Strategies
19.3.
Fonterra Co-Operative Group Limited
19.3.1.
Company Details
19.3.2.
Company Overview
19.3.3.
Product Offerings
19.3.4.
Key Developments
19.3.5.
Financial Analysis
19.3.6.
SWOT Analysis
19.3.7.
Business Strategies
19.4.
Friesland Campina.
19.4.1.
Company Details
19.4.2.
Company Overview
19.4.3.
Product Offerings
19.4.4.
Key Developments
19.4.5.
Financial Analysis
19.4.6.
SWOT Analysis
19.4.7.
Business Strategies
19.5.
Ingredion Germany GmbH
19.5.1.
Company Details
19.5.2.
Company Overview
19.5.3.
Product Offerings
19.5.4.
Key Developments
19.5.5.
Financial Analysis
19.5.6.
SWOT Analysis
19.5.7.
Business Strategies
19.6.
NATVIE Healthcare Ltd
19.6.1.
Company Details
19.6.2.
Company Overview
19.6.3.
Product Offerings
19.6.4.
Key Developments
19.6.5.
Financial Analysis
19.6.6.
SWOT Analysis
19.6.7.
Business Strategies
19.7.
NISSAN SUGAR CO., LTD
19.7.1.
Company Details
19.7.2.
Company Overview
19.7.3.
Product Offerings
19.7.4.
Key Developments
19.7.5.
Financial Analysis
19.7.6.
SWOT Analysis
19.7.7.
Business Strategies
19.8.
Quantum Hi-Tech (Guangdong) Biological
Co., Ltd.
19.8.1.
Company Details
19.8.2.
Company Overview
19.8.3.
Product Offerings
19.8.4.
Key Developments
19.8.5.
Financial Analysis
19.8.6.
SWOT Analysis
19.8.7.
Business Strategies
19.9.
VW-Ingredients
19.9.1.
Company Details
19.9.2.
Company Overview
19.9.3.
Product Offerings
19.9.4.
Key Developments
19.9.5.
Financial Analysis
19.9.6.
SWOT Analysis
19.9.7.
Business Strategies
19.10.
Yakult Pharmaceutical.
19.10.1.
Company Details
19.10.2.
Company Overview
19.10.3.
Product Offerings
19.10.4.
Key Developments
19.10.5.
Financial Analysis
19.10.6.
SWOT Analysis
19.10.7. Business Strategies
19.11.
Other market participants
20. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.